Related Experiment Videos
Carnitine in dried blood spots: a method suitable for neonatal screening
R J Barns1, F G Bowling, G Brown
1Division of Chemical Pathology, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|February 28, 1991
Summary
A new method quantifies free and total carnitine in dried blood spots, aiding neonatal screening for carnitine deficiencies. This quantitative determination is crucial for early diagnosis and treatment.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Neonatal Medicine
Background:
- Carnitine deficiency, a metabolic disorder, can be primary or secondary.
- Early detection is vital for preventing severe health complications in newborns.
- Dried blood spots offer a minimally invasive sample type for neonatal screening.
Purpose of the Study:
- To develop and validate a quantitative method for assessing carnitine levels.
- To enable reliable neonatal screening for primary and secondary carnitine deficiencies.
- To establish reference ranges for free and total carnitine in dried blood spots.
Main Methods:
- Quantitative determination of free and total carnitine.
- Utilized dried blood spot samples.
- Statistical analysis to determine confidence intervals and medians.
Main Results:
- The method accurately quantifies both free and total carnitine.
- Established 95% confidence intervals: 26-76 mumol/l for free carnitine (median 44) and 35-102 mumol/l for total carnitine (median 60).
- Demonstrated suitability for large-scale neonatal screening programs.
Conclusions:
- The described method provides a reliable tool for neonatal carnitine deficiency screening.
- Quantitative carnitine analysis in dried blood spots is feasible and effective.
- Supports timely diagnosis and intervention for affected infants.